Accelerate to discover

Back to filter

Related topics

IncuCyte webinar: high throughput approach to developing T- Cell immunotherapies

Sartorius

Jun 17, 2019

Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have...

IncuCyte virtual event: Dimension of time - from culture to assay

Sartorius

Jun 5, 2019

This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....

Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps

BioNano Genomics

May 15, 2019

Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...

IncuCyte webinar recording: Human Neurons in vitro, next-gen models for neurological disease

Sartorius

Apr 23, 2019

The ability to generate and manipulate human neurons in vitro is an exciting advance that enables the validation,...

Jul 24, 2019

Rapid, Quantitative CEST Imaging with MRI Fingerprinting

Bruker Biospin

Apr 16, 2019

With applications spanning almost any disease area, from cancer, stroke, through to cardiac metabolism disorders, this...

Monitoring cancer treatments with immuno-PET webinar

Bruker Biospin

Mar 8, 2019

In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...

Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software

Cytek Biosciences

Jan 17, 2019

Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...

Jul 24, 2019

IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy

Sartorius

Jan 11, 2019

The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...

Show all topics (10)

Real-time analysis of cellular phagocytosis - Tuesday, June 20, 2017, 5 pm CEST

Jun 1, 2017

Tim Dale, Director of Biology, Europe, Essen BioScience

Alongside intense efforts to exploit T-cells as immunotherapies for cancer (e.g. checkpoint inhibitors, CAR-T, T-cell metabolism), researchers are increasingly considering other immune cell types for novel targets. One example is the enhancement of macrophage function via inhibitors of CD47 “don’t-eat-me” signalling proteins, enabling tumour cells to evade clearance by neighbouring phagocytes (Kim et al, 2012, Leukemia 26, 2538–2545). To identify new CD47 and phagocyte modulators, novel, direct and validated assays with throughput commensurate to drug discovery are required.

In this mini-webinar Tim Dale will:

-Illustrate how real-time live-cell analysis using pH-sensitive fluorescent probe-labelled target cells can be used to visualize and quantify phagocytosis.
-Share data on the pro-phagocytic effects of anti-CD47 antibodies.
-Demonstrate how other live-cell phenotypic assays (e.g. apoptosis, proliferation) are used to validate mechanisms of action.

Register now

Webinar

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

Sartorius

Essen BioScience (part of Sartorius), is a team of engineers and biologists with deep expertise in cell-based assays. We invent, manufacture, supply and support cell-based assay instrumentation, reagents and protocols.

Related products

Real-time automated measurements of cell health, movement and function, inside your incubator

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey